• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drug Facts Label Powerpoint
Drug Facts Label Powerpoint

... Alcohol Warning: If you consume 3 or more alcoholic drinks every day, ask your doctor whether you should take acetaminophen or other pain relievers or fever reducers. Acetaminophen may cause liver damage. Sore Throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or ...
Nanostructured Silicon – Applications in Drug Delivery
Nanostructured Silicon – Applications in Drug Delivery

... the commercial life of their currently marketed drugs, and drug delivery is a core application for BioSilicon in what is a rapidly growing market. The specialised drug delivery market is in excess of US$50 billion, with an estimated US$80 billion worth of pharmaceutical products expected to have com ...
Section A: Answer four of the following five questions. Each question
Section A: Answer four of the following five questions. Each question

... The benefits of statin treatment are particularly evident in patients with hypercholesterolemia but no history of cardiovascular disease Statins are an example of a drug where clinical response is strongly linked to dose Statins are generally well tolerated drugs with some rare but serious side effe ...
Long Term Effects GHB - Dr. Tamerin Capellino
Long Term Effects GHB - Dr. Tamerin Capellino

... 2.4% of 8th graders 4.3% of 10th graders 6.2 % of 12th graders GHB is legally available in over 50 countries worldwide including Mexico. XTC imported mainly from Australia and Canada ...
save - Tufts Center for the Study of Drug Development
save - Tufts Center for the Study of Drug Development

... human genes, with the humanized products containing more human protein sequence than the chimeric versions. Orphan drug — Drugs developed for rare diseases and conditions, which, in the United States, affect fewer than 200,000 people, or, in the European Union, affect 5 per 10,000 people or fewer. B ...
Drug Therapy in Pediatric Patients
Drug Therapy in Pediatric Patients

... B - Animal studies do not indicate a risk to the fetus and there are no controlled human studies, or animal studies do show an adverse effect on the fetus but well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus. C - Studies have’ shown that the drug exerts animal ...
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring

... • Drugs with low Vd are contained mostly in the plasma, because . . . – They are highly water soluble (plasma water content is higher than tissues), or – They are highly protein bound (which prevents them from freely diffusing into tissues ...
Nervous System
Nervous System

... the nervous system, or in the blood stream as well  Enzymes break down drugs into metabolites  Metabolites can be active or inactive ...
tibbi̇ farmakoloji̇ anabi̇li̇m dali doktora programi
tibbi̇ farmakoloji̇ anabi̇li̇m dali doktora programi

... Local Credit : 3 ECTS Credit: 6 Pharmacological principles and clinical drug research in humans with official regulations, new drug developing technique, ethics committees, tasks and approval criteria, clinical trials (legal regulations and provisions of the standard stages of a trial, ...
Clinical Therapeutics Lecture #6 Drugs for Sexual Dysfunction Drug
Clinical Therapeutics Lecture #6 Drugs for Sexual Dysfunction Drug

... Female Orgasmic Disorder – Persistent of recurrent delay or absence of orgasm after a normal excitement phase of sexual activity that is assessed as adequaett in focus intensity and duration, Causes: Similar to Sexual Arousal Disorder, SSRI’s Selective Serotonin Receptor Inhibitors – proven to preve ...
the Presentation of ICS
the Presentation of ICS

... Several other surrogate markers are under evaluation • The phase of clinical testing of new anti-TB drugs time-consuming, “gold standard” to assess efficacy of anti-TB regimens in phase III clinical trials, relapse rate 2 years after completing treatment. ...
L1-pharmacology of t..
L1-pharmacology of t..

... Eye drops • Eye drops- most common • one drop = 50 µl • volume of conjunctival cul-de-sac 7-10 µl ...
Why do we need Pharmacovigilance?
Why do we need Pharmacovigilance?

... likelihood of whether an ADR is actually due to the drug rather than the result of other factors. Probability is assigned by a score (definite, probable, possible or doubtful). ...
Drug Awareness Study Guide
Drug Awareness Study Guide

... B) "Cold turkey because you stop taking drugs immediately." C) "Detoxification centers because health care professionals help you quit the drugs safely." D) "If you never start and you always say "No!" then you won't have to quit, and that's the best way." 2. (U4C3L1:Q4) A friend of yours just had a ...
New Approaches to Filling the Gap in Tuberculosis Drug Discovery
New Approaches to Filling the Gap in Tuberculosis Drug Discovery

... a useful therapy will emerge, given that only about one compound in 20 successfully emerges from an antiinfective drug discovery program [7]. Since new drugs for TB should only be used in combination, to prevent resistance, it would be a responsible act of global leadership to take whatever steps ar ...
Pharmacology Update 1999 - Distance Learning Center for
Pharmacology Update 1999 - Distance Learning Center for

...  It is more potent than hydrocodone (Lortab, Vicodin) and has a greater potential for abuse ...
Nursing 3703 Pharmacology in Nursing
Nursing 3703 Pharmacology in Nursing

... variable effects in this scenario  Know the actions, usual dosages and side effects of medications  Closely monitor renal and liver function tests  Monitor serum protein and albumin levels ...
drug approval process for the treatment of alzheimer`s disease
drug approval process for the treatment of alzheimer`s disease

... conditions. This testing starts the process of identifying common side effects, as well as finding out how high the dosages can be before adverse side effects occur. Phase 1 studies generally take at least one year to complete. If they look promising, they go into Phase 2 trials. Clinical trials – P ...
Aging - Pharmacology of. Geriatric Therapy
Aging - Pharmacology of. Geriatric Therapy

... ≥60 yrs old 4. 85 yrs old and over: “Oldest old” will increase to 18 million by 2050 5. Centenarians will increase from 57,000 persons (1996) to 447,000 (2040) ...
Anaesthetic implications of psychoactive drugs
Anaesthetic implications of psychoactive drugs

... A rare but significant side-effect of both the typical and the atypical antipsychotic drugs is the neuroleptic malignant syndrome. First described in the 1960s, it is characterized by hyperthermia, autonomic dysfunction, and muscle rigidity. Relevant to the anaesthetist is that the differential diag ...
How can value be measured and valued?
How can value be measured and valued?

... Health Technology Assessment (HTA) is the scientific evaluation of medical technologies regarding their effectiveness, appropriateness, efficiency as well as social and ethical aspects and implications. HTA is bridging the gap between the worlds of Science and Politics. In times of general health bu ...
Epilepsy
Epilepsy

...  Epilepsy is usually controlled but not cured with medication.  Up to 80% of patients can expect partial or complete control of seizures with appropriate treatment.  20% no response to treatment  non pharmacological approach e.g. surgry, etc  Antiepileptic drugs are indicated when there is two ...
Clinical Cases in Toxicology
Clinical Cases in Toxicology

...  antidote for LA (bupivacaine) toxicity since late 1990s  growing body of evidence for use in overdose with other drugs ...
Slide 1
Slide 1

... adverse drug effect (“Prescribing Cascade”) • Remember that over-the-counter drugs, supplements, and herbals can be the culprit ...
a review on drug approval process for us, europe and india
a review on drug approval process for us, europe and india

... approved to be marketed in the European Union. These two steps are clinical trial application and marketing authorization application. There are 28 member states in the European Union (as of July, 2013); Clinical Trial Applications are approved at the member state level, whereas marketing authorizat ...
< 1 ... 99 100 101 102 103 104 105 106 107 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report